-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Tuberculosis (TB) is one of the leading causes of death worldwide.
About 1.
5 million people died of tuberculosis in 2018.
Nearly 90% of the cases were from developing countries.
At the same time, many low-income and middle-income countries The prevalence of hypertension has risen sharply, accounting for nearly 75% of global hypertension cases
.
There is considerable overlap between countries with a high burden of tuberculosis and hypertension
Tuberculosis (TB) is one of the leading causes of death worldwide.
This retrospective cohort study included all patients over 18 years of age who were treated for sensitive tuberculosis at National Taiwan University Hospital from 2000 to 2016, and then assessed the use of hypertension and CCB in the first 9 months of tuberculosis treatment, as well as Association of all-cause and infection- related mortality in patients with sputum smear microscopy and positive sputum culture at the second and sixth months
.
Among the 2894 patients, 1052 (36.
4%) had hypertension
.
Multivariate analysis showed that hypertension was associated with an increase in all-cause mortality ([HR], 1.
This study found that within 9 months of starting tuberculosis treatment, all-cause mortality and infection-related mortality in hypertensive patients increased
.
The use of DHP-CCB may reduce all-cause mortality in patients with hypertensive tuberculosis
This study found that within 9 months of starting tuberculosis treatment, all-cause mortality and infection-related mortality in hypertensive patients increased
Original source:
Vignesh Chidambaram.
The Impact of Hypertension and Use of Calcium Channel Blockers on Tuberculosis Treatment Outcomes.
Leave a message here
